Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Biomarkers predictive of therapeutic responsiveness to chimeric antigen receptor therapy and uses thereof

Biomarkers predictive of therapeutic responsiveness to chimeric antigen receptor therapy and uses thereof

US Patent 10774388 · Granted Sep 15, 2020

Estimated economic value: $25,355,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chimeric antigen receptors and uses thereof2025
Route stacking in a fleet routing system2025
CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric a2025
CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric a2025
CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric a2025
Fleet routing control system and method2025
Rapamycin derivatives2025
Methods of treating non-arteritic anterior ischemic optic neuropathy2025
Methods for improving the efficacy and expansion of immune cells2025
Methods for improving the efficacy and expansion of immune cells2025
Methods for improving the efficacy and expansion of immune cells2025
Treatment of cancer using humanized anti-BCMA chimeric antigen receptor2025